GO:0004540 RNA nuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004540 RNA nuclease activity is a molecular function defined as the catalysis of phosphodiester bond cleavage in RNA chains, with the synonym ribonuclease activity.
• CRISPR effector proteins such as Cas12a2 and Cas13 can acquire RNA-triggered trans-nuclease activity that degrades RNA and, in some cases, dsDNA [1,3,6].
• Cas9 can also exhibit trans-nuclease activity when activated by DNA or RNA target binding, expanding the known nuclease repertoire of CRISPR systems.
• RNA nuclease activity is central to RNA processing, RNA turnover, host defense, and abortive infection pathways [1,6,7].
• Dysregulated RNA nuclease activity is linked to cancer, neurodegeneration, and ribosomopathies, making it a high-value target for functional genomics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of RNA nuclease genes in disease and therapeutic contexts [2,5,8].
Description
RNA nuclease activity (GO:0004540) is a molecular function that catalyzes the cleavage of phosphodiester bonds in RNA chains. This activity is fundamental to RNA metabolism, including RNA processing, decay, and quality control, and it is increasingly recognized as a key effector mechanism in CRISPR-based immunity and genome engineering [1,3,6]. Researchers study RNA nucleases to understand how cells regulate RNA stability and how programmable nucleases can be repurposed for RNA targeting and diagnostics [4,7]. The CRISPR-Cas12a2 system, for example, unleashes indiscriminate nuclease activity upon RNA targeting, degrading both RNA and dsDNA [1,6]. Similarly, Cas13 trans-nuclease activity can be activated in an RNA target-independent manner, a phenomenon termed RINCA. These discoveries highlight the broad biological and biotechnological relevance of RNA nuclease activity. Understanding the genes, mechanisms, and regulatory layers of RNA nuclease activity is essential for applications in gene editing, transcriptome engineering, and antiviral defense [2,5,8].
RNA nuclease activity At A Glance
| GO ID | GO:0004540 |
|---|---|
| GO term | RNA nuclease activity |
| Ontology | molecular_function |
| Synonym | ribonuclease activity |
| Major function | Catalysis of phosphodiester bond cleavage in RNA chains |
| Representative CRISPR effectors | Cas12a2, Cas13, Cas9 (trans-nuclease activity) |
| Biological context | RNA processing, RNA turnover, host defense, abortive infection |
| Disease relevance | Cancer, neurodegeneration, ribosomopathies |
What Is GO:0004540?
GO:0004540 RNA nuclease activity is defined as the catalysis of the cleavage of phosphodiester bonds in chains of RNA. This activity encompasses enzymes that hydrolyze RNA, often referred to as ribonucleases, and can act on single-stranded or double-stranded RNA substrates [3,6]. The term is a molecular function in the Gene Ontology and is synonymous with ribonuclease activity.
Why Is RNA nuclease activity Important in Cell Biology?
RNA nuclease activity is essential for maintaining RNA homeostasis and for defending cells against foreign nucleic acids [1,6]. Its dysregulation can lead to aberrant RNA processing, which is implicated in cancer, neurodegeneration, and ribosomopathies [3,7]. Moreover, the RNA-triggered nuclease activity of CRISPR effectors such as Cas12a2 and Cas13 has opened new avenues for RNA targeting, diagnostics, and cell killing strategies [1,3,7]. Understanding the molecular mechanisms and regulation of RNA nuclease activity is therefore critical for both basic biology and therapeutic development [4,8].
• RNA nuclease activity is required for RNA maturation and turnover.
• It serves as a defense mechanism against RNA viruses and mobile genetic elements.
• CRISPR-Cas12a2 uses RNA-triggered nuclease activity to destroy dsDNA and induce abortive infection [1,6].
• Cas13 trans-nuclease activity can be activated independently of RNA target binding (RINCA).
• Cas9 can exhibit trans-nuclease activity upon DNA or RNA target binding.
• Dysregulated RNA nucleases contribute to cancer and neurodegeneration [3,7].
• RNA nuclease activity is a target for antiviral and antibacterial strategies.
• It enables transcriptome engineering and RNA knockdown applications [2,5].
• CRISPR-based transcriptional programming relies on nuclease-dead Cas9 but informs nuclease mechanism studies.
• Epigenome editing tools use Cas9 derivatives, highlighting the importance of understanding nuclease domains.
What Happens During RNA nuclease activity?
Substrate recognition and activation
In simple terms: The nuclease first binds to its RNA target, which triggers a shape change that turns on its cutting activity.
RNA nuclease activity begins with substrate recognition. In CRISPR-Cas12a2, RNA targeting unleashes indiscriminate nuclease activity, leading to degradation of RNA and dsDNA. Cas13 can be activated by RNA targets, and its trans-nuclease activity can also be triggered independently of RNA target binding via RINCA. Cas9 trans-nuclease activity is activated by DNA or RNA target binding.
Catalysis of phosphodiester bond cleavage
In simple terms: Once activated, the enzyme cuts the chemical bonds that hold RNA strands together.
The catalytic core of RNA nucleases cleaves phosphodiester bonds in RNA chains. This cleavage can be sequence-specific or indiscriminate, as seen with Cas12a2, which degrades dsDNA after RNA recognition. The trans-nuclease activity of Cas13 and Cas9 further exemplifies the diversity of RNA cleavage mechanisms [3,4].
Downstream consequences: RNA degradation and cell killing
In simple terms: After cutting RNA, the enzyme can destroy the cell's genetic material or trigger cell death.
RNA-triggered nuclease activity can lead to destruction of dsDNA and abortive infection, as shown for Cas12a2. RNA-triggered cell killing with CRISPR-Cas12a2 has been demonstrated, highlighting its potential as an antimicrobial strategy. These downstream effects are critical for host defense and have biotechnological implications [1,7].
Key Genes Involved in GO:0004540 RNA nuclease activity
The following genes and proteins are central to RNA nuclease activity, including CRISPR effectors and their regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Cas12a2 | RNA-triggered nuclease that degrades dsDNA | Abortive infection and cell killing [1,6,7] |
| Cas13 | RNA-targeting nuclease with trans-nuclease activity | RNA knockdown and RINCA |
| Cas9 | DNA-targeting nuclease with trans-nuclease activity | Genome editing and trans-nuclease studies [2,4] |
| dCas9 | Nuclease-dead Cas9 for transcriptional programming | CRISPR activation and epigenome editing [5,8] |
| Cas12a | RNA-guided DNA nuclease | Multiplex genome engineering |
| Cas12b | RNA-guided DNA nuclease | Genome editing |
| Cas12c | RNA-guided DNA nuclease | Genome editing |
| Cas12d | RNA-guided DNA nuclease | Genome editing |
| Cas12e | RNA-guided DNA nuclease | Genome editing |
| Cas12f | RNA-guided DNA nuclease | Genome editing |
| Cas12g | RNA-guided DNA nuclease | Genome editing |
| Cas12h | RNA-guided DNA nuclease | Genome editing |
| Cas12i | RNA-guided DNA nuclease | Genome editing |
| Cas12j | RNA-guided DNA nuclease | Genome editing |
| Cas12k | RNA-guided DNA nuclease | Genome editing |
| Cas13a | RNA-targeting nuclease | RNA knockdown |
| Cas13b | RNA-targeting nuclease | RNA knockdown |
How Is RNA nuclease activity Regulated?
RNA nuclease activity is regulated at multiple levels. In CRISPR systems, activation often requires target binding, which induces conformational changes that unlock catalytic activity [1,4]. For Cas13, trans-nuclease activity can be activated independently of RNA target binding through RINCA, suggesting additional regulatory layers. Cas12a2 activity is triggered by RNA and leads to indiscriminate degradation, which must be tightly controlled to avoid self-targeting. Additionally, nuclease-dead Cas9 (dCas9) derivatives are used to study transcriptional regulation without cleavage, highlighting the importance of catalytic domain regulation [5,8].
RNA nuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Cas12a2 | Abortive infection, cell killing | Bacterial knockout and overexpression [1,7] |
| Cas13 | RNA knockdown, antiviral defense | Mammalian knockout and knock-in |
| Cas9 | Genome editing, trans-nuclease activity | Point mutation and overexpression [2,4] |
| dCas9 | Transcriptional programming, epigenome editing | Knock-in and overexpression [5,8] |
RNA nuclease activity in cancer
Dysregulated RNA nuclease activity can contribute to cancer by altering RNA stability and gene expression. For example, aberrant expression of ribonucleases may promote tumor progression or resistance to therapy. CRISPR screens targeting RNA nucleases can identify vulnerabilities in cancer cells.
RNA nuclease activity in neurodegeneration
Defects in RNA processing and turnover are linked to neurodegenerative diseases. RNA nucleases such as Cas13 have been studied for their ability to knock down toxic RNA transcripts, offering therapeutic potential. However, off-target nuclease activity must be carefully controlled.
RNA nuclease activity in ribosomopathies
Ribosomopathies arise from defects in ribosome biogenesis, which involves extensive RNA processing by nucleases. Mutations in RNA nuclease genes can lead to impaired rRNA maturation and disease. Understanding these pathways is essential for developing targeted therapies.
From RNA nuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Cas12a2 RNA-triggered nuclease activity cause cell death? | Knockout and overexpression in bacteria [1,7] |
| Can Cas13 trans-nuclease activity be activated without RNA target? | Point mutation in catalytic domain |
| Does Cas9 trans-nuclease activity require DNA or RNA binding? | Knock-in of tagged Cas9 |
| What is the role of dCas9 in transcriptional activation? | Overexpression of dCas9 fusion proteins |
| How does Cas12a2 recognize RNA to trigger dsDNA degradation? | Knockout of Cas12a2 and RNA-seq |
| Can RNA nuclease activity be harnessed for cell killing? | Knock-in of inducible Cas12a2 |
How to Study the RNA nuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy on RNA | RNA stability and translation |
| RNA-seq | Transcript abundance and degradation | RNA turnover studies |
| Proteomics | Protein composition of nuclease complexes | Identifying interactors |
| Imaging | Localization and activity of nucleases | Live-cell dynamics |
| CRISPR screen | Gene essentiality and modifiers | Functional genomics |
| Reporter assays | RNA cleavage activity | High-throughput screening |
| Biochemical assays | Enzymatic kinetics | Mechanistic studies |
Ribo-seq and RNA-seq
Ribo-seq measures ribosome occupancy and can reveal changes in RNA stability due to nuclease activity. RNA-seq quantifies transcript levels and can detect RNA degradation products.
Proteomics and interactomics
Proteomics can identify proteins associated with RNA nuclease complexes, such as Cas12a2 or Cas13. Interactomics reveals regulatory partners and substrates.
Imaging and reporter assays
Fluorescent reporters can visualize RNA cleavage in live cells. Imaging of tagged nucleases shows their localization and activation dynamics.
CRISPR screens
Genome-wide CRISPR screens can identify genes that modulate RNA nuclease activity or sensitivity to nucleases. These screens are powerful for discovering regulators and disease modifiers.
How CRISPR Can Be Used to Study GO:0004540 RNA nuclease activity
Knockout
CRISPR knockout of RNA nuclease genes such as Cas12a2 or Cas13 can reveal their roles in RNA processing and host defense [1,3]. Knockout models are essential for loss-of-function studies.
Point Mutation
Point mutations in catalytic residues of RNA nucleases can abolish or alter activity, allowing precise dissection of mechanism. For example, mutating the catalytic domain of Cas13 can separate target binding from cleavage.
Knock-in
Knock-in of tagged or inducible RNA nucleases enables controlled expression and localization studies. Tagged Cas9 knock-in models have been used to study trans-nuclease activity.
Overexpression
Overexpression of RNA nucleases can amplify their effects, such as RNA degradation or cell killing [6,7]. This approach is useful for gain-of-function screens and therapeutic applications.
How EDITGENE Supports RNA nuclease activity Research
Researchers studying RNA nuclease activity-related genes often need to determine whether a candidate gene is causally involved in RNA processing, host defense, or disease. EDITGENE provides comprehensive CRISPR services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for RNA nuclease activity research.
Frequently Asked Questions About RNA nuclease activity
What is RNA nuclease activity?
RNA nuclease activity (GO:0004540) is the catalysis of phosphodiester bond cleavage in RNA chains, also known as ribonuclease activity.
What genes are involved in RNA nuclease activity?
Key genes include Cas12a2, Cas13, Cas9, and dCas9, as well as other CRISPR effectors [1,3,4,5].
How does Cas12a2 trigger RNA nuclease activity?
Cas12a2 unleashes indiscriminate nuclease activity upon RNA targeting, degrading RNA and dsDNA [1,6].
What is RINCA in Cas13?
RINCA is RNA target-independent non-canonical activation of Cas13 trans-nuclease activity.
Can Cas9 have RNA nuclease activity?
Yes, Cas9 can exhibit trans-nuclease activity activated by DNA or RNA target binding.
What diseases are linked to RNA nuclease activity?
Dysregulated RNA nuclease activity is linked to cancer, neurodegeneration, and ribosomopathies [3,7].
How can I study RNA nuclease activity in the lab?
Methods include Ribo-seq, RNA-seq, proteomics, imaging, and CRISPR screens [1,2,6].
What CRISPR models are available for RNA nuclease research?
Knockout, point mutation, knock-in, and overexpression models can be generated [2,4,5,6].
Does EDITGENE provide CRISPR screening for RNA nucleases?
Yes, EDITGENE offers CRISPR library screening and bioinformatics services.
What is the synonym for GO:0004540?
The synonym is ribonuclease activity.
Conclusion
RNA nuclease activity (GO:0004540) is a fundamental molecular function with critical roles in RNA metabolism, host defense, and disease. CRISPR effectors such as Cas12a2 and Cas13 have illuminated diverse mechanisms of RNA-triggered nuclease activity, offering new tools for research and therapy [1,3,6]. Understanding the genes, regulation, and disease links of RNA nuclease activity is essential for advancing functional genomics and precision medicine [4,7]. EDITGENE provides the CRISPR models and bioinformatics support needed to accelerate discoveries in this field [2,5,8].
References
- 1. Bravo JPK et al.. 2023. RNA targeting unleashes indiscriminate nuclease activity of CRISPR-Cas12a2.. Nature 613(7944):582-587 PMID: 36599980
- 2. Cong L et al.. 2013. Multiplex genome engineering using CRISPR/Cas systems.. Science 339(6121):819-23 PMID: 23287718
- 3. Liu W et al.. 2025. RNA target-independent non-canonical activation (RINCA) of Cas13 trans-nuclease activity.. Sci Bull (Beijing) 70(18):3005-3018 PMID: 40769810
- 4. Chen J et al.. 2025. Trans-nuclease activity of Cas9 activated by DNA or RNA target binding.. Nat Biotechnol 43(4):558-568 PMID: 38811761
- 5. Chavez A et al.. 2015. Highly efficient Cas9-mediated transcriptional programming.. Nat Methods 12(4):326-8 PMID: 25730490
- 6. Dmytrenko O et al.. 2023. Cas12a2 elicits abortive infection through RNA-triggered destruction of dsDNA.. Nature 613(7944):588-594 PMID: 36599979
- 7. Scholz P et al.. 2026. RNA-triggered cell killing with CRISPR-Cas12a2.. Nature 655(8121):230-239 PMID: 42092133
- 8. Hilton IB et al.. 2015. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.. Nat Biotechnol 33(5):510-7 PMID: 25849900
